Opus Genetics (NASDAQ:IRD) 주식

OPUS GENETICS INC

Opus Genetics

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline includes adeno-associated virus (AAV)-based gene therapies that address mutations in genes that cause different forms of bestrophinopathy, Leber congenital amaurosis (LCA), and retinitis pigmentosa. The pipeline also includes Phentolamine Ophthalmic Solution 0.75%, a non-selective alpha-1 and alpha-2 adrenergic antagonist to reduce pupil size, and APX3330, a novel small-molecule inhibitor of Ref-1 to slow the progression of non-proliferative diabetic retinopathy.

Opus Genetics Inc

Iren SpA

Iridium Communications Inc - Common Stock

Iridium Communications Inc

Despite fears of a sharp slowdown in the labor market, the official nonfarm payrolls report for May showed stronger-than-expected job growth, underscoring the resilience of the U.S. <a href="https://www.benzinga.com/news/econ-s">economy amid macroeconomic uncertainties.</a>
The economy added 139,000 nonfarm payrolls in May, beating expectations of 130,000 yet cooling <a href="https://www.benzinga.com/markets/economic-data/25/06/45812372/us-labor-markets-defies-tariff-concerns-as-nonfarm-payrolls-wages-top-expectations-in-may" target="_blank" rel="noopener">from the previous 147,000.</a> Wage growth also exceeded expectations, with average hourly earnings rising 0.4% month over month and 3.9% year over year. The unemployment rate remained steady at 4.2%.
President Donald Trump celebrated the strong May jobs report, calling the figures "great numbers," while renewing his public pressure on Fed Chair Jerome Powell, urging him <a href="https://www.benzinga.com/markets/economic-data/25/06/45818251/trump-cheers-strong-jobs-data-renews-attack-on-feds-powell-rates-should-be-much-lower">to lower interest rates.</a>
According to Trump, borrowing costs should be "much lower" as they are costing the U.S. economy "a fortune," suggesting the need to refinance maturing debt.
His remarks came after the Congressional Budget Office released updated estimates for Trump's sweeping tax bill, which is projected to add $2.4 trillion to the federal deficit over the next decade.
<h3 class="wp-block-heading">Political Spat Between Trump And Musk Hits Tesla Stock</h3>
A clash between Elon Musk and Trump <a href="https://www.benzinga.com/news/politics/25/06/45817556/trump-musk-feud-sends-betting-markets-into-overdrive-heres-what-traders-see-next">erupted on Thursday</a> after the tech billionaire publicly slammed the tax bill, claiming it was pushed through Congress too fast and never shared with him during his brief tenure as head of the Department of Government Efficiency.
Musk advocated for a leaner federal budget and accused the legislation of reckless spending.
Trump claimed Musk had gone crazy after losing access to government electric vehicle mandates. The president also floated the idea of scrapping all government contracts with Musk's companies, including SpaceX and Starlink, as a cost-saving measure for the budget.
Tensions reached a boiling point when Musk posted: "Time to drop the really big bomb: Trump is in the Epstein files. That is the real reason they have not been made public," yet offering no evidence to support the claim.
The feud sent shockwaves through markets, triggering Tesla Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) worst trading session of the year. Shares tumbled 14% on Thursday, erasing $152 billion in market value and capping a brutal week of double-digit losses.
On Friday, the S&amp;P 500 – tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) – closed at 6,000 points, gaining 1.5% for the week.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/06/45820264/top-2-alternatives-to-tesla-after-the-musk-trump-breakup">Top 2 Alternatives To Tesla After The Musk-Trump Breakup </a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Equities

Broad U.S. Equity ETFs

Global

Econ #s

ETFs

TSLA

US Labor Market Shows Resilience, Tesla Slumps After Trump-Musk Feud: This Week In Markets

News

Kohls Says On June 5, Announced Closing Of Our Monroe, Ohio E-Fulfillment Center; Will Recognize Cumulative Pre-Tax Charges Of About $25M-$30M; Expect Charges Related To Monroe EFC Closing To Be Incurred In Q2 & Q3 2025

Offerings

MTEN

Mingteng International Files For Mixed Shelf Of Up to $100M

East West Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) has outperformed the market over the past 5 years by 4.13% on an annualized basis producing an average annual return of 17.44%. Currently, East West Bancorp has a market capitalization of $12.99 billion. 
Buying $100 In EWBC: If an investor had bought $100 of EWBC stock 5 years ago, it would be worth $218.85 today based on a price of $94.26 for EWBC at the time of writing.
<h3>East West Bancorp's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749240937_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

EWBC

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

Hyatt Hotels Corporation ("Hyatt" or the "Company") (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/H#NYSE">H</a>), a leading global hospitalitycompany, announced today that all required regulatory approvals have been obtained for its previously announced cash tender offer to purchase all of the outstanding ordinary shares of Playa Hotels &amp; Resorts N.V. ("Playa") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLYA#NASDAQ">PLYA</a>) for $13.50 per share in cash, less any applicable withholding taxes and without interest. The offer is being made pursuant to the previously announced purchase agreement, dated February 9, 2025 (the "Purchase Agreement"), among Hyatt, HI Holdings Playa B.V. ("Buyer") and Playa.

PLYA

Hyatt Secures All Regulatory Approvals For $13.50 Per Share Cash Tender Offer To Acquire Playa Hotels & Resorts Pursuant To February 2025 Purchase Agreement

Raytech Holding Files For Offering Of Up To 30M Ordinary Shares

Wall Street analysts rerated Broadcom Inc&nbsp;(NASDAQ: AVGO)&nbsp;after it reported second-quarter financial results on Thursday. The company reported <a target="_blank" href="https://www.benzinga.com/markets/earnings/25/06/45803595/broadcom-q2-earnings-revenue-eps-beat-estimates-driven-by-robust-demand-for-ai-networking-company-sees-acceleration-in-ai-revenue-ahead" rel="noreferrer noopener">second-quarter revenue</a> of $15 billion, up 20%, beating&nbsp;analyst estimates of $14.99 billion, driven by continued momentum in AI semiconductor solutions and VMware.
The semiconductor company reported second-quarter adjusted earnings of $1.58 per share, beating analyst estimates of $1.56.
The second-quarter&nbsp;AI revenue grew&nbsp;46%&nbsp;to over&nbsp;$4.4 billion,&nbsp;driven by robust demand for AI networking.
Also read: <a target="_blank" href="https://www.benzinga.com/analyst-stock-ratings/analyst-color/25/06/45751360/broadcoms-flexes-ai-muscle-hyperscalers-buying-in" rel="noreferrer noopener">Broadcom Tomahawk 6 Flexes AI Muscle, Hyperscalers Are Buying In</a>
Broadcom expects third-quarter revenue of approximately $15.8 billion, versus estimates of $15.79 billion.&nbsp;
<h2 class="wp-block-heading">Analyst Ratings</h2>
<ul class="wp-block-list">
<li>JP Morgan analyst Harlan Sur maintained Broadcom with an Overweight and raised the <a href="https://www.benzinga.com/quote/AVGO/analyst-ratings" target="_blank" rel="noreferrer noopener">price target from</a> $250 to $325.</li>
<li>Truist Securities analyst William Stein reiterated Broadcom with a Buy and raised the price target from $267 to $295.</li>
<li>Rosenblatt analyst Kevin Cassidy maintained Broadcom with a Buy and raised the price target from $223 to $340.</li>
<li>Cantor Fitzgerald analyst Matthew Prisco reiterated Broadcom with an Overweight and a $300 price target.</li>
<li>Benchmark analyst Cody Acree maintained Broadcom with a Buy and raised the price target from $255 to $315.</li>
</ul>
<h2 class="wp-block-heading">JP Morgan</h2>
JP Morgan analyst Sur is encouraged by the Broadcom team&#8217;s strong line of sight to fiscal 2026 AI revenue profile driven by strong cloud/hyperscaler capex spending trends with continued focus on AI training combined with accelerating AI inference workloads, continued ramp of Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google&#8217;s next-gen TPU v6/v7 3nm AI accelerator ASICs, ramp up of Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) 3nm, and continued strong adoption of ethernet networking.
The continued substantial AI revenues underscore Broadcom&#8217;s strong design win pipeline and confirm Sur&#8217;s belief that internally developed custom ASIC silicon programs offer opportunities for differentiation, efficiency gains, and improved silicon economics.
The analyst said that the fundamentals of cyclical semiconductor businesses are stabilizing across most areas. He stressed that Broadcom continues successfully converting and upselling to its VCF full-stack solution in the infrastructure software business.
Even during macro volatility, the team drives a solid revenue growth profile. Sur estimated that Free Cash Flow generation will be $26 billion this year, up 34% year over year, implying a substantial dividend raise at the end of this fiscal year. Broadcom remains his top pick in semiconductors.
<h2 class="wp-block-heading">Truist Securities</h2>
Broadcom delivered only a modest upside to calendar first-quarter results and the calendar second-quarter guide. Still, Truist Securities analyst Stein noted investors were expecting a more significant beat, considering results from Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) and capex outlooks from hyperscale companies.
Stein stated Broadcom&#8217;s long-term position in AI is stable or potentially improving, with significant customer additions (3 current and 4 potential additions) suggesting meaningful potential upside. He also anticipated long-term upside at VMWare.
Broadcom&#8217;s non-AI semi-sales in the calendar first quarter aligned with Stein&#8217;s estimate. Still, management guided to flat quarter-on-quarter growth, implying $4 billion in the calendar second quarter and a ~5% miss compared to his model (not surprising to him, considering that he noted excess channel inventory).
AI computes (custom accelerators) made up ~60% of total AI sales in the calendar first quarter, implying ~$2.6 billion (14% below his estimate of $3.1 billion).
However, Stein remarked that AI networking delivered $1.8 billion in sales, up 170% Y/Y and 33% above his estimate of $1.3 billion. He said that Broadcom expects to shift back to 70/30 compute/networking going forward, implying a double-digit quarter-over-quarter decline in AI networking revenue and an acceleration in custom silicon.
<h2 class="wp-block-heading">Rosenblatt</h2>
Rosenblatt analyst Cassidy writes in the analyst note that Broadcom reported a mostly inline quarter with AI revenue up 46% Q/Q and guided to 60% Y/Y growth.
The analyst said that based on good visibility from its three XPU customers, management believes this growth rate can continue into 2026.
He was interested in adopting Broadcom&#8217;s Ethernet products to scale up connectivity and scaling out. Scale-up unit volumes are 5x to 10x higher than scale-out, Cassidy said.
The analyst noted that the applications are for both LLM training and inference. He said that with three hyper-scale customers ramping up production, management discussed the other four XPU prospects. Cassidy continued recommending the stock for its strong custom ASIC capabilities.
<h2 class="wp-block-heading">Cantor Fitzgerald</h2>
While the second-quarter results and third-quarter guide may be viewed as only a &#8220;skinny beat,&#8221; underneath the covers was a very bullish outlook from Broadcom management, Cantor analyst Prisco stated. Broadcom remains Prisco&#8217;s top pick.
AI Semi revenues were guided at +16% Q/Q and 60% Y/Y for the third quarter, with management then suggesting improved visibility today that gives them confidence that the AI semiconductor business can grow at this ~60% rate for all of fiscal 2025 and 2026, the analyst said.
He said that AI semiconductor revenues are projected to reach $20 billion+ in fiscal 2025 and $30 billion+ in fiscal 2026, delivering meaningful upside to consensus into calendar 2026.
Prisco remarked that non-AI Semiconductor revenues continue to bounce along the bottom while the cash cow Infrastructure Software grows modestly.
<h2 class="wp-block-heading">Benchmark</h2>
On a relatively modest beat and raise, Broadcom&#8217;s shares are off about 4% after hours as investors grapple with results that were closer to the small upside that pummelled Marvell&#8217;s shares last week versus the stronger outperformance delivered by Nvidia when adjusting for their Chinese exposure, analyst Acree stated.
The analyst writes that he understands investors taking profits, particularly considering the company&#8217;s $120-plus run since its recent early April lows of about $139.
He continues to believe Broadcom represents an attractive opportunity as the number two provider of advanced accelerated compute and networking solutions to the AI industry, with direct leverage to the steadily increasing capex budgets of a growing number of the market&#8217;s largest hyperscale investors.
Price Action: AVGO stock is trading lower by 5.25% to $243.28 at the last check Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/45813754/taiwan-semiconductor-powers-alphawaves-2nm-chip-breakthrough-for-faster-ai-and-hpc-connectivity" target="_blank" rel="noreferrer noopener">Taiwan Semiconductor Powers Alphawave&#8217;s 2nm Chip Breakthrough For Faster AI And HPC Connectivity</a></li>
</ul>
Photo by Ken Wolter via Shutterstock

Price Target

Reiteration

Analyst Ratings

Tech

AAPL

AVGO

GOOGL

NVDA

Broadcom Gets Mixed Reactions As Modest Earnings Beat Sparks Profit-Taking

According to several experts in the sector, Bitcoin ETFs and cryptocurrency-related ETFs have made significant progress since launching in January 2024 <a href="https://www.benzinga.com/etfs/currency-etfs/25/01/42971053/bitcoin-etfs-enter-2025-after-massive-first-year">and setting inflow records</a>.
Here's what three Bitcoin-ETF experts had to say about the sector&#8217;s growth, why people are choosing Bitcoin ETFs, what the U.S. buying Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) could mean for demand and validation, and what comes next for cryptocurrency ETFs.
Beating Expectations: The launch of Bitcoin ETFs has been an &#8220;amazing journey&#8221; that could be &#8220;just beginning,&#8221; WisdomTree Global Head of Research Chris Gannatti said at <a href="https://www.youtube.com/watch?v=g-tme4GtysQ">Benzinga's recent ETF event.</a>
"At WisdomTree, we've been amazed to watch the appetite, the adoption," Gannatti said.
Gannatti said it's clear there was pent-up demand for Bitcoin ETFs and everyone has now seen "incredible growth."
WisdomTree was one of the first companies with a Bitcoin ETF with the WisdomTree Bitcoin Fund (BATS:<a class="ticker" href="https://www.benzinga.com/stock/BTCW#BATS">BTCW</a>).
Bitwise Asset Management Head of Research Ryan Rasmussen echoed the early success of Bitcoin ETFs with his company behind the Bitwise Bitcoin ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BITB#NYSE">BITB</a>) and several other crypto-related ETFs.
"The adoption and performance of Bitcoin ETFs since they launched in the US since last January is just incredible," Rasmussen said.
Rasmussen said Bitcoin ETFs broke the one-year record for inflows and continue to see strong demand.
"We're extremely excited about it. Just getting started."
After the launch of the initial batch of Bitcoin ETFs came other funds like the Innovator Uncapped Bitcoin 20 Floor ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/QBF#BATS">QBF</a>), which offers limited downside for investors.
Innovator Director of Product Strategy Andrew Nelson said the initial growth of Bitcoin ETFs is what spurred the company launching a crypto ETF.
"There's room for everybody," Nelson said.
Nelson said Innovator's fund creates additional investment opportunities for investors and another tool in their tool kit when looking for exposure to Bitcoin.
Read Also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/04/45018551/senator-on-digital-assets-committee-buys-more-bitcoin-etf-shares-2025-is-the-year-for-digital-assets">Senator On Digital Assets Committee Buys More Bitcoin ETF Shares: &#8216;2025 Is The Year For Digital Assets&#8217;</a>
Why Bitcoin ETFs?: When asked why there's room for Bitcoin ETFs alongside investing directly in Bitcoin, the expert panel didn't flinch.
Nelson said Bitcoin ETFs like the one from Innovator provide "unique exposure" for investors.
Summarizing his company's ETF in three sentences, he said it's, "Bitcoin, 20% max loss, and no cap."
The Innovator fund offers an uncapped upside while providing a 20% max loss each quarter for investors. Nelson said this is not something you can engineer on your own just by holding Bitcoin.
Rasmussen echoed this sentiment saying there are different things ETFs can do like derivatives and options along with getting access to "institutional grade custody" of Bitcoin.
With Bitcoin ETFs, there's less risk for asset managers than worrying about self-custody and other aspects for clients, Rasmussen added.
Countries and Companies Adding Bitcoin: Another key growth topic for Bitcoin and Bitcoin ETFs could be the stockpiling of the leading cryptocurrency by countries and companies.
Gannatti said that some see the degree of success Michael Saylor has had with Strategy Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) buying Bitcoin and they want to follow it.
"People who have achieved great success get great attention," Gannatti said.
Gannatti also said the US being more crypto-friendly isn't a done deal, but things are changing.
"The current administration is pushing the ball down the field in a positive direction."
Without giving a price prediction, Gannatti said if the only goal is to get the price of Bitcoin to go up fast, the U.S. buying Bitcoin could be the quickest way.
Rasmussen highlighted the sector&#8217;s change. The fact that a person predicting some of the things that happened five years ago would have been laughed at and called crazy, he added.
"I think it's crazy that we're seeing corporations and governments buy Bitcoin, not in a bad way," Rasmussen said.
Rasmussen referenced how GameStop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) recently bought Bitcoin. More companies are saying they're adding the cryptocurrency to hedge against national debt, inflation, and geopolitical concerns.
"I still think we're in the early stages of seeing mass adoption by governments and corporations."
Rasmussen added that, "no government wants to be the last mover when it comes to this."
Pension funds that have yet to invest in Bitcoin say they&#8217;d feel comfortable adding cryptocurrency to their portfolios if the U.S. purchases Bitcoin, the panelist added.
"I think that is one of those monumental moments,&#8221; he added.
More demand from countries and corporations could lead the price of Bitcoin higher, Nelson said.
Nelson said the idea is that high demand drives prices higher in a supply-constrained environment. The U.S. buying Bitcoin could be a positive action for the sector. Yet, Nelson added, it might not be the same initial demand that happened when Bitcoin ETFs launched.
"We think it's a positive for the space."
What's Next: Bitwise predicts Bitcoin will hit $200,000 by the end of 2025 and $1 million by 2029. Rasmussen said these are predictions and not investment advice but show confidence in the long term.
Going forward, the company is also launching more ETFs in the cryptocurrency space. This includes covered call income strategy funds around public crypto-companies like Strategy, MARA Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) and Coinbase Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>).
"We're spending a lot of time thinking about what products do investors want access to," Rasmussen said. 
Innovator has just one current cryptocurrency ETF — QBF. However, the company is closely monitoring the space and the options market to see where the demand is, Nelson said, adding, "We're looking at Ethereum of course, because of its already approved nature.&#8221;
Innvoator also monitors Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) and XRP CRYPTO:XRP). 
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/new-etfs/25/02/43599972/new-bitcoin-etf-limits-losses-to-20-offers-risk-controlled-exposure">New Bitcoin ETF Limits Losses To 20%, Offers Risk-Controlled Exposure</a></li>
</ul>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
 <iframe loading="lazy" title="Crypto Panel - Virtual ETF Event" width="500" height="281" src="https://www.youtube.com/embed/ozqSFOpMooE?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Specialty ETFs

Exclusives

Interview

$BTC

$ETH

$SOL

$XRP

Bitwise Bitcoin ETF Common Shares of Beneficial Interest

BITB

WisdomTree Bitcoin Fund WisdomTree Bitcoin Fund

BTCW

COIN

MARA

MSTR

Innovator ETFs Trust Innovator Uncapped Bitcoin 20 Floor ETF - Quarterly

EXCLUSIVE: Bitcoin ETF Experts On Past, Present And Future Of Sector — Why US Buying BTC Could Be 'Monumental Moment'

<a href="https://www.bloomberg.com/news/articles/2025-06-06/tesla-s-leader-of-optimus-humanoid-robot-program-leaves-company">https://www.bloomberg.com/news/articles/2025-06-06/tesla-s-leader-of-optimus-humanoid-robot-program-leaves-company</a>

General

'Tesla's Leader of Optimus Humanoid Robot Program Leaves Company'- Bloomberg

Opendoor Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPEN#NASDAQ">OPEN</a>) (the "Company," "Opendoor," "we," "our" or "us"), a leading e-commerce platform for residential real estate transactions, filed a preliminary proxy statement. The proxy statement was furnished in connection with the solicitation of proxies by Opendoor's Board of Directors (the "Board") for use at the Company's Special Meeting of Stockholders to be held on Monday, July 28, 2025, at 9:30 a.m. Pacific Time.
Our Board has adopted and is recommending that our stockholders approve amendments to our Certificate of Incorporation, to effect a reverse stock split of our common stock ("Common Stock") at a ratio ranging from any whole number between 1‑for‑10 and 1‑for‑50, with the exact ratio within such range to be determined by the Board in its discretion (the "Reverse Stock Split"), subject to the Board's authority to determine when to file the amendment and to abandon the other amendments notwithstanding prior stockholder approval of such amendments.

Stock Split

OPEN

Opendoor Technologies Files Preliminary Proxy For July 28 Special Meeting Seeking Shareholder Approval For Reverse Stock Split At Ratio Between 1-For-10 And 1-For-50

On June 5, 2025, Aytu BioPharma, Inc. (the "Company") entered into an underwriting agreement (the "Underwriting Agreement") with Lake Street Capital Markets, LLC, as underwriter (the "Underwriter"), relating to the public offering of 1,366,668&nbsp;shares of the Company's common stock, par value $0.0001 per share ("Common Stock"), at a purchase price per share of Common Stock of $1.50&nbsp;(the "Offering Price"), and 8,233,332&nbsp;prefunded warrants in lieu of Common Stock ("Prefunded Warrants") at a purchase price per Prefunded Warrant of $1.4999, each of which enables the investor to purchase one share of Common Stock at an exercise price of $0.0001. Pursuant to the Underwriting Agreement, the Company granted the Underwriter a 30-day option to purchase up to an additional 1,440,000 shares of Common Stock at the Offering Price, less any underwriting discounts and commissions.
Net proceeds from the offering will be approximately $12.9&nbsp;million (or approximately $14.9&nbsp;million if the Underwriter exercises its option to purchase additional shares of Common Stock in full) after deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company. The Company intends to use the net proceeds of this offering for general corporate purposes, working capital and general and administrative expenses, and to execute on a transaction that will enable the Company to exclusively commercialize EXXUATM (gepirone) extended-release tablets.

AYTU

Aytu BioPharma Prices Public Offering Of 1.37M Shares At $1.50 And 8.23M Prefunded Warrants At $1.4999, Expecting Up To $14.9M In Net Proceeds To Support EXXUA Commercialization And Corporate Operations

A federal crackdown on hemp-derived cannabinoids advanced in Congress this week, triggering alarm across the $28 billion U.S. hemp industry. A House subcommittee approved a spending bill that would redefine hemp in a way that bans most intoxicating cannabinoid products, including THCA flower, delta-8 and even some full-spectrum CBD.
The proposed legislation, backed by Rep. Andy Harris, now moves to the full House Appropriations Committee for markup on June 11. If enacted, it could reshape the cannabis landscape far beyond hemp, affecting retailers, manufacturers and state regulators across the country.
All this sets the stage for next week's <a href="https://www.benzinga.com/cannabis-conference">Benzinga Cannabis Capital Conference</a>, taking place June 8–10 at the Marriott Magnificent Mile in Chicago. With more than 120 speaker, the event will focus on capital raising, M&amp;A, state-level policy and how operators are adapting in the face of intensifying federal scrutiny.
<a class="" href="https://www.benzinga.com/cannabis-conference">Get your tickets here</a>.
From California's record-breaking sales decline to regulatory confusion in Argentina and legalization momentum in Chile and Ukraine, here's everything that moved the global cannabis conversation this week.
<h3 class="wp-block-heading">Congress Advances Hemp THC Ban, Industry Warns Of Collapse</h3>
A GOP-led House subcommittee has advanced a bill that would redefine hemp and effectively ban most intoxicating cannabinoid products, including THCA, delta-8, delta-10 and full-spectrum CBD. The measure, included in the FY2026 Agriculture-FDA appropriations bill, passed in a 9–7 vote and now heads to the full House Appropriations Committee for markup on June 11.
Backed by Rep. Andy Harris (R-MD), the bill proposes narrowing hemp's legal uses to fiber, grain, and industrial applications, with an exemption for FDA-approved drugs like Epidiolex. The U.S. Hemp Roundtable warned that the language could destroy a $28.4 billion market and cost more than 300,000 jobs.
Marijuana Moment first reported the bill's advancement and its potential to shut down the market for unregulated cannabinoids, many of which emerged under the 2018 Farm Bill.
"This would eliminate the vast majority of hemp-derived products sold nationwide," said Jonathan Miller, general counsel for the Roundtable. "It's a farmer-crushing, job-killing ban."
Critics, including the Wine &amp; Spirits Wholesalers of America and the National Cannabis Industry Association, say the language is overly broad and risks fueling the illicit market. Analysts like Todd Harrison noted that banning intoxicating hemp would not kill the crop itself but would benefit state-licensed cannabis programs by curbing unregulated competitors.
<a href="https://www.benzinga.com/cannabis/25/06/45802969/federal-crackdown-on-hemp-derived-thc-cannabinoids-advances-in-congress-industry-warns-of-collapse">Full Benzinga article</a>
<h2 class="wp-block-heading">Business Moves</h2>
<h3 class="wp-block-heading">MediPharm Labs Sells BC Facility, Expands EU Production</h3>
MediPharm Labs Corp. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/LABS#TSX">LABS</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/MEDIF#OTCQB">MEDIF</a>) sold its Hope, British Columbia facility to Rubicon Organics (TSXV:<a class="ticker" href="https://www.benzinga.com/stock/ROMJ#TSXV">ROMJ</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/ROMJF#OTCQX">ROMJF</a>) for $4.5 million in cash. CEO David Pidduck said the deal will improve MediPharm's cash position and sharpen its focus on pharmaceutical-grade cannabis, particularly through expanded cultivation at its EU GMP-certified Ontario site.
<h3 class="wp-block-heading">Budr Acquires Three Botanist Dispensaries In Connecticut</h3>
Budr Cannabis, which already operates four locations in Connecticut and one in New York, acquired three Botanist dispensaries from Canopy Growth's U.S. subsidiary. The Botanist will remain active in other states including Massachusetts, New York and New Jersey.
<h3 class="wp-block-heading">Village Farms Completes Fresh Produce Divestiture</h3>
Village Farms International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>) finalized its exit from the produce business, closing the privatization of its greenhouse-grown fruits and vegetables division. CEO Michael DeGiglio says the move strengthens Village Farms' focus on international cannabis growth, with 160 acres of greenhouse facilities now allocated primarily to cannabis production.
<h3 class="wp-block-heading">Vangst Acquires Se7en Staffing</h3>
Cannabis hiring platform Vangst announced its third acquisition in a year: Se7en Staffing &amp; Employment Solutions, a Missouri-based firm. No financial terms were disclosed. The move reinforces Vangst's position as a leading cannabis workforce provider.
<h2 class="wp-block-heading">Policy &amp; Regulation</h2>
<h3 class="wp-block-heading">Ohio Doubles Daily Flower Purchase Limit</h3>
Ohio cannabis consumers can now purchase up to 2.5 ounces of flower per day, more than doubling the previous 1-ounce limit. The Ohio Division of Cannabis Control issued updated guidance following strong sales since adult-use launched in August 2024. As of late May, recreational purchases had surpassed $539 million.
<h3 class="wp-block-heading">California's Cannabis Sales Hit Five-Year Low</h3>
California's legal cannabis market posted its biggest quarterly drop in history, with Q1 2025 taxable sales falling 11% year-over-year to $1.088 billion. Experts blame a combination of overregulation, rising taxes, and competition from the illicit market. A scheduled excise tax hike from 15% to 19% on July 1 threatens to worsen the trend—though a new bill to delay the increase passed the Assembly unanimously.
<a class="" href="https://www.sfgate.com/cannabis/article/california-cannabis-sales-data-2025-20359112.php">Full article via SFGATE</a>
<h3 class="wp-block-heading">California Assembly Votes to Delay Tax Hike</h3>
The California Assembly voted 74–0 in favor of delaying the cannabis excise tax increase until 2030–31. Sponsored by Assemblymember Matt Haney, the bill now moves to the Senate. UFCW Local 1167 and other labor groups applauded the vote as a win for licensed operators.
<h2 class="wp-block-heading">Global Developments</h2>
<h3 class="wp-block-heading">Ukraine Approves First Medical Cannabis Import</h3>
Ukraine's State Medical Service issued its first permit to import cannabis-based medicines, expanding a program legalized in 2023 after years of war-related trauma. The approved product is registered in the country and marks a key step in opening Ukraine's market to international supply chains. President Volodymyr Zelensky has consistently backed medical cannabis as a tool for public health and recovery.
<a href="https://www.marijuanamoment.net/ukraine-officials-approve-countrys-first-ever-permit-to-import-medical-marijuana-products/?utm_source=newsletteremail.benzinga.com&amp;utm_medium=newsletter&amp;utm_campaign=musk-s-doge-team-leaves-weed-and-destruction-in-gov-office-ohio-s-cannabis-win-california-s-loss&amp;_bhlid=d8b8aa5ea20cc023dca8b4322de155c2ff1b2782">Read more on Marijuana Moment</a>
<h3 class="wp-block-heading">Chile Reopens Debate on Cannabis Legalization</h3>
Chile's Congress reintroduced a long-stalled bill to legalize adult-use cannabis, including home grow and nonprofit collectives. The proposal, backed by the "Regulación por la Paz" coalition and newly supported by President Gabriel Boric, would authorize up to six plants per person and regulated dispensaries. The government's proposed roadmap mirrors Uruguay's public-health-driven model, with four rollout phases planned through 2027.
Read more on <a class="" href="https://elplanteo.com/chile-proyecto-legalizacion-cannabis/">El Planteo</a>
<h3 class="wp-block-heading">Argentina's Cannabis Regulation Enters Legal Limbo</h3>
In Argentina, government agencies INASE and ARICCAME are locked in a bureaucratic standoff that's jeopardizing the legal cannabis industry. Operators have been blocked from renewing licenses, registering genetics, or accessing critical systems, effectively pushing them into regulatory gray zones. Meanwhile, the Health Ministry is demanding compliance with requirements that can't be met, due to the same administrative freeze.
Continue reading on <a class="" href="https://elplanteo.com/inase-ariccame-resolucion-bloqueo/">El Planteo</a>
<h2 class="wp-block-heading">Culture &amp; Industry</h2>
<h3 class="wp-block-heading">Weedmaps Launches Apparel Collab with Robin Eisenberg</h3>
Weedmaps teamed up with LA-based artist Robin Eisenberg for a limited-edition apparel and accessories collection. Known for her cosmic, body-positive illustrations, Eisenberg brings a vibrant twist to cannabis lifestyle fashion. The line includes denim jackets, cowgirl-themed tees, glow-in-the-dark socks, and home accessories—all centered around empowerment and creativity.
Weedmaps says the capsule reflects the inclusive spirit of cannabis culture and marks its first explicitly female-forward drop.
<h2 class="wp-block-heading">Recommended Reads</h2>
<ul class="wp-block-list">
<li><a class="" href="https://www.benzinga.com/cannabis/25/06/45755890/thc-drinks-arent-the-new-beer-theyre-something-else-says-tilray">THC Drinks Aren&#8217;t The New Beer, They&#8217;re Something Else, Says Tilray</a> Tilray's Sam Garfinkel discusses why hemp-derived beverages play a different role than alcohol.</li>
<li><a class="" href="https://www.benzinga.com/cannabis/25/06/45754417/this-us-cannabis-company-did-what-none-of-its-peers-could-in-q1-grow">This US Cannabis Company Did What None Of Its Peers Could In Q1: Grow</a> A rare quarter of positive growth, analyzed against an industry-wide slump.</li>
<li><a class="" href="https://www.forbes.com/sites/javierhasse/2025/06/02/triploid-cannabis/">‘Mutant Marijuana' Is Changing How Weed Is Grown (But It's Not What You Think)</a> An inside look at triploid cannabis genetics and their potential to reshape cultivation.</li>
</ul>

Cannabis

Politics

MEDIF

ROMJF

TSX:LABS

TSX:ROMJ

TSXV:ROMJ

This Week In Cannabis: America's Crackdown Down On Hemp, Global Reform, Industry Gathering In Chicago

<a href="https://register.epo.org/application?number=EP18868355" title="https://register.epo.org/application?number=EP18868355">https://register.epo.org/application?number=EP18868355</a>

Biotech

BDSX

Biodesix Has Been Granted European Patent Number EP3698144 Titled "COMPOSITIONS, METHODS AND KITS FOR DIAGNOSIS OF LUNG CANCER".

ZCMD

Zhongchao Files For Mixed Shelf Of Up to $300M

PolyPid Ltd.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPD#NASDAQ">PYPD</a>), ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will host a conference call and webcast to report topline data for the SHIELD II Phase 3 trial, evaluating D-PLEX100 for the prevention of surgical site infections in patients undergoing abdominal colorectal surgery, on Monday, June 9, at 8:30 a.m. ET.
To ensure you are connected prior to the beginning of the call, PolyPid suggests registering a minimum of 5 minutes before the start of the call.

PYPD

PolyPid Will Host A Conference Call And Webcast To Report Topline Data For The SHIELD II Phase 3 Trial, Evaluating D-PLEX100 For The Prevention Of Surgical Site Infections In Patients Undergoing Abdominal Colorectal Surgery, On Monday, June 9, At 8:30 a.m. ET

BLMZ

BloomZ Granted Second 180-Day Extension By Nasdaq To Regain $1.00 Bid Price Compliance

Whales with a lot of money to spend have taken a noticeably bullish stance on Super Micro Computer.
Looking at options history for Super Micro Computer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) we detected 33 trades.
If we consider the specifics of each trade, it is accurate to state that 45% of the investors opened trades with bullish expectations and 30% with bearish.
From the overall spotted trades, 7 are puts, for a total amount of $317,156 and 26, calls, for a total amount of $1,650,718.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $30.0 to $70.0 for Super Micro Computer over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Super Micro Computer's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Super Micro Computer's whale trades within a strike price range from $30.0 to $70.0 in the last 30 days. 
<h3>Super Micro Computer Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749240336_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SMCI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$3.3</td>
<td>$3.25</td>
<td>$3.29</td>
<td>$50.00</td>
<td>$203.7K</td>
<td>13.8K</td>
<td>955</td>
</tr>
<tr>
<td>SMCI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$11.4</td>
<td>$11.3</td>
<td>$11.3</td>
<td>$40.00</td>
<td>$169.5K</td>
<td>8.6K</td>
<td>160</td>
</tr>
<tr>
<td>SMCI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$12.6</td>
<td>$12.45</td>
<td>$12.45</td>
<td>$45.00</td>
<td>$134.4K</td>
<td>601</td>
<td>109</td>
</tr>
<tr>
<td>SMCI</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/13/25</td>
<td>$1.48</td>
<td>$1.47</td>
<td>$1.48</td>
<td>$42.00</td>
<td>$134.2K</td>
<td>2.0K</td>
<td>1.6K</td>
</tr>
<tr>
<td>SMCI</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/13/25</td>
<td>$2.96</td>
<td>$2.93</td>
<td>$2.93</td>
<td>$40.00</td>
<td>$99.9K</td>
<td>1.8K</td>
<td>672</td>
</tr>
</tbody>
</table>

<h3>About Super Micro Computer</h3>
Super Micro Computer Inc provides high-performance server technology services to cloud computing, data centers, Big Data, high-performance computing, and the "Internet of Things" embedded markets. Its solutions include server, storage, blade, and workstations to full racks, networking devices, and server management software. The firm follows a modular architectural approach, which provides flexibility to deliver customized solutions. The Company operates in one operating segment that develops and provides high-performance server solutions based upon an innovative, modular, and open-standard architecture. More than half of the firm's revenue is generated in the United States, with the rest coming from Europe, Asia, and other regions.
After a thorough review of the options trading surrounding Super Micro Computer, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Super Micro Computer Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 21,353,284, the SMCI's price is up by 3.04%, now at $42.01. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 60 days.</li>
</ul>
<h3>Professional Analyst Ratings for Super Micro Computer</h3>
In the last month, 2 experts released ratings on this stock with an average target price of $40.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Raymond James downgraded its action to Outperform with a price target of $41. 
&#x2A; Consistent in their evaluation, an analyst from Mizuho keeps a Neutral rating on Super Micro Computer with a target price of $40. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Super Micro Computer, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

SMCI

Check Out What Whales Are Doing With SMCI

High-rolling investors have positioned themselves bullish on Toast (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>), and it's important for retail traders to take note. 
\This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in TOST often signals that someone has privileged information.
Today, Benzinga's options scanner spotted 11 options trades for Toast. This is not a typical pattern.
The sentiment among these major traders is split, with 63% bullish and 27% bearish. Among all the options we identified, there was one put, amounting to $56,745, and 10 calls, totaling $443,082.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $30.0 and $47.0 for Toast, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Toast's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Toast's significant trades, within a strike price range of $30.0 to $47.0, over the past month.
<h3>Toast Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749240330_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TOST</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$15.85</td>
<td>$15.65</td>
<td>$15.83</td>
<td>$30.00</td>
<td>$71.2K</td>
<td>13.1K</td>
<td>50</td>
</tr>
<tr>
<td>TOST</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$2.0</td>
<td>$1.95</td>
<td>$1.95</td>
<td>$40.00</td>
<td>$56.7K</td>
<td>7.7K</td>
<td>1.5K</td>
</tr>
<tr>
<td>TOST</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$10.05</td>
<td>$9.8</td>
<td>$9.9</td>
<td>$47.00</td>
<td>$48.5K</td>
<td>6.3K</td>
<td>564</td>
</tr>
<tr>
<td>TOST</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$10.2</td>
<td>$9.9</td>
<td>$9.97</td>
<td>$47.00</td>
<td>$47.8K</td>
<td>6.3K</td>
<td>328</td>
</tr>
<tr>
<td>TOST</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/15/27</td>
<td>$11.15</td>
<td>$9.9</td>
<td>$9.95</td>
<td>$47.00</td>
<td>$47.7K</td>
<td>6.3K</td>
<td>275</td>
</tr>
</tbody>
</table>

<h3>About Toast</h3>
Toast is a US-based restaurant technology company that provides point-of-sale, payment processing, and various software services to 140,000 restaurant locations across the United States as of the end of March 2025. The firm generates sales from software subscription fees, a percentage take rate from each financial transaction it processes, loan origination and servicing fees from its Toast Capital arm, and hardware installation and professional services. Unlike competitors, Toast intermediates every payment transaction on its platform; it processed some $159 billion in gross platform volume in 2024. The firm's product offerings span point-of-sale systems, inventory and payroll management, delivery integration, e-commerce ordering, reservation management, and loyalty programs.
In light of the recent options history for Toast, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Current Position of Toast</h3>
<ul>
<li>Trading volume stands at 4,198,083, with TOST's price up by 2.45%, positioned at $43.87.</li>
<li>RSI indicators show the stock to be may be approaching overbought.</li>
<li>Earnings announcement expected in 60 days.</li>
</ul>
<h3>Professional Analyst Ratings for Toast</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $45.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Piper Sandler persists with their Neutral rating on Toast, maintaining a target price of $37. 
&#x2A; An analyst from Truist Securities has revised its rating downward to Buy, adjusting the price target to $48. 
&#x2A; An analyst from Wells Fargo has decided to maintain their Overweight rating on Toast, which currently sits at a price target of $46. 
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Overweight rating on Toast with a target price of $50. 
&#x2A; Maintaining their stance, an analyst from BMO Capital continues to hold a Outperform rating for Toast, targeting a price of $45. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Toast, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

TOST

This Is What Whales Are Betting On Toast

Financial giants have made a conspicuous bullish move on Rivian Automotive. Our analysis of options history for Rivian Automotive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) revealed 9 unusual trades.
Delving into the details, we found 55% of traders were bullish, while 44% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $257,445, and 4 were calls, valued at $396,900.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $12.0 to $22.0 for Rivian Automotive over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Rivian Automotive's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Rivian Automotive's significant trades, within a strike price range of $12.0 to $22.0, over the past month.
<h3>Rivian Automotive Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749240325_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RIVN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$1.0</td>
<td>$0.98</td>
<td>$0.98</td>
<td>$20.00</td>
<td>$222.9K</td>
<td>29.8K</td>
<td>2.5K</td>
</tr>
<tr>
<td>RIVN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/20/26</td>
<td>$2.26</td>
<td>$2.25</td>
<td>$2.25</td>
<td>$17.00</td>
<td>$112.9K</td>
<td>10.4K</td>
<td>501</td>
</tr>
<tr>
<td>RIVN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/13/25</td>
<td>$0.79</td>
<td>$0.76</td>
<td>$0.79</td>
<td>$14.50</td>
<td>$79.0K</td>
<td>1.2K</td>
<td>2.0K</td>
</tr>
<tr>
<td>RIVN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/13/25</td>
<td>$0.99</td>
<td>$0.95</td>
<td>$0.95</td>
<td>$14.50</td>
<td>$65.6K</td>
<td>1.2K</td>
<td>1.0K</td>
</tr>
<tr>
<td>RIVN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$6.85</td>
<td>$6.8</td>
<td>$6.8</td>
<td>$20.00</td>
<td>$57.8K</td>
<td>3.2K</td>
<td>85</td>
</tr>
</tbody>
</table>

<h3>About Rivian Automotive</h3>
Rivian Automotive Inc is an automotive manufacturer that develops and builds electric vehicles ("EVs") as well as software and services. It launches its consumer vehicle business with the R1 platform consisting of two vehicles: the R1T, and the R1S. The company has two reportable segments: Automotive, which derives the majority of revenue, and Software and Services segment. The Automotive reportable segment derives its revenues and cost of revenues from the production and sale of new EVs and the sale of regulatory credits generated by the production and sale of EVs. The Software and services reportable segment derives its revenues and cost of revenues primarily from remarketing, vehicle repair and maintenance services, and vehicle electrical architecture and software development services.
Following our analysis of the options activities associated with Rivian Automotive, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Rivian Automotive</h3>
<ul>
<li>Trading volume stands at 20,412,319, with RIVN's price up by 1.56%, positioned at $13.99.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 60 days.</li>
</ul>
<h3>What Analysts Are Saying About Rivian Automotive</h3>
Over the past month, 4 industry analysts have shared their insights on this stock, proposing an average target price of $15.5.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Stifel has decided to maintain their Buy rating on Rivian Automotive, which currently sits at a price target of $18. 
&#x2A; Reflecting concerns, an analyst from Jefferies lowers its rating to Hold with a new price target of $16. 
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Neutral rating for Rivian Automotive, targeting a price of $15. 
&#x2A; An analyst from Mizuho has decided to maintain their Neutral rating on Rivian Automotive, which currently sits at a price target of $13. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Rivian Automotive with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

RIVN

Looking At Rivian Automotive's Recent Unusual Options Activity

Know Labs Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KNW#NASDAQ">KNW</a>) shares soared Friday afternoon after the company announced it will be acquired by Goldeneye 1995 LLC, an entity led by fintech investor and former Ripple Chief Risk Officer Greg Kidd. The stock closed on Friday up 206.97% at $1.56 a share.
What To Know: Goldeneye will acquire a controlling stake in Know Labs through a combination of 1,000 Bitcoin and cash to retire debt and fund operations, valuing shares at $0.335. The deal, expected to close in third-quarter 2025, will install Kidd as CEO and chairman.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45821970/hive-digital-technologies-stock-jumps-10-on-bitcoin-mining-milestone">HIVE Digital Technologies Stock Jumps 10% On Bitcoin Mining Milestone</a>
A major component of the strategy is the use of Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) as a treasury asset, giving Know Labs significant exposure to digital assets. Management will use a multiple of net asset value metric to evaluate market valuation against Bitcoin holdings, which are expected to make up 82% of the company's market cap, assuming BTC is priced at $105,000.
"This Bitcoin treasury strategy is a forward-looking move to drive sustainable growth," said Kidd.
Company founder Ron Erickson will lead a new division focused on non-invasive diagnostics research and serve as Vice Chairman. The transaction was unanimously approved by Know Labs&#8217; board.
Read Also: <a href="https://www.benzinga.com/trading-ideas/movers/25/06/45818020/nio-stock-volatile-after-mixed-q1-earnings-cost-cuts-and-global-expansion-in-focus">NIO Stock Volatile After Mixed Q1 Earnings, Cost Cuts And Global Expansion In Focus</a>
<h1 class="wp-block-heading">How To Buy KNW Stock</h1>
Besides going to a brokerage platform to purchase a share — or fractional share — of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, Know Labs is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, KNW has a 52-week high of $4.20 and a 52-week low of $0.33.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/commodities/25/06/45819573/silver-tops-36-triggering-a-generational-technical-breakout" target="_blank" rel="noreferrer noopener">Silver Tops $36, Triggering A Generational Technical Breakout</a> Image: Shutterstock </li>
</ul>

Movers

Know Labs (KNW) Stock Soars Over 200% On Acquisition Deal, Bitcoin Strategy

Press Releases

Opus Genetics to Participate in Upcoming Investor Conference in April

Opus Genetics Files Definitive Proxy Statement and Sends Letter to Stockholders Highlighting the Company's Transformation and Progress

Health Care

Opus Genetics Announces One-Month Clinical Data from Pediatric Patient in Phase 1/2 Trial of OPGx-LCA5 Gene Therapy in Inherited Retinal Diseases

Founder Mina Sooch Issues Open Letter to Opus Genetics Stockholders Following Withdrawal of the Restore Value Slate Amid Dilutive Financing and Governance Concerns

Management

PRISM MarketView Spotlights Opus Genetics in New Q&A with CEO George Magrath

Opus Genetics Announces Presentation of OPGX-LCA5 Gene Therapy Data at ARVO; 12 Month Phase 1/2 Results Support Potential to Restore to Meaningful Vision

Opus Genetics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for OPGx-LCA5 Gene Therapy Candidate

Opus Genetics Announces Presentations on Inherited Retinal Disease Programs at Medical Conferences in May

Earnings

Opus Genetics Announces Financial Results for First Quarter 2025 and Provides Corporate Update

Opus Genetics Announces LYNX-2 Phase 3 Trial Met its Primary Endpoint for Phentolamine Ophthalmic Solution 0.75% in Keratorefractive Patients with Visual Disturbances Under Mesopic, Low-Contrast Conditions

Comments

Opus Genetics

뉴스

파트너 / 기고자

벤징가 글로벌